Cited by 1,821Electroconvulsive Therapy StudiesPoisoning and overdose treatmentsPharmacovigilance and Adverse Drug Reactions

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

The Serotonin Syndrome

Boyer, Edward W., Shannon, Michael·2005·New England Journal of Medicine

DOI 10.1056/nejmra041867

Open this paper in CoChat — free account

Abstract

The serotonin syndrome is a potentially life-threatening drug reaction that may result from therapeutic medication use, self-poisoning, or interactions between drugs.

Integrity signals

Registry

Crossref · 10.1056/nejmra041867

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,025
The serotonin syndrome
Sternbach, H. A. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.6.705 · Cited by 1,349
The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity
Dunkley, E. J. C., Isbister, G. K., Sibbritt, D. W., Dawson, A. H., & Whyte, I. M. (2003) · QJM · doi:10.1093/qjmed/hcg109 · Cited by 1,032
Neuroleptic malignant syndrome
Levenson, J. L. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.10.1137 · Cited by 984
2002 annual report of the American association of poison control centers toxic exposure surveillance system
Watson, W. A., Litovitz, T. L., Rodgers, G. C., Klein‐Schwartz, W., Youniss, J., Rose, S. R., Borys, D. J., & May, M. E. (2003) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(03)00088-3 · Cited by 481
Interactions Between Herbal Medicines and Prescribed Drugs
Izzo, A., & Ernst, E. (2012) · Drugs · doi:10.2165/00003495-200161150-00002 · Cited by 464
Relative Toxicity of Selective Serotonin Reuptake Inhibitors (SSRIs) in Overdose
Isbister, G. K., Bowe, S. J., Dawson, A. H., & Whyte, I. M. (2004) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-120037428 · Cited by 432
The Libby Zion Case
Asch, D. A., & Parker, R. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803243181209 · Cited by 396
Effects of Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy on Serotonergic Symptoms in Newborns and Cord Blood Monoamine and Prolactin Concentrations
Laine, K., Heikkinen, T., Ekblad, U., & Kero, P. O. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.720 · Cited by 329
Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity
Parrott, A. C. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00711-0 · Cited by 325

Show all 49 references

Research works printed but not linked: 8

Sampson E, 1999, Br J Gen Pract, 49, 867
Mackay FJ, 1999, Br J Gen Pract, 49, 871
Hoyer D, 1994, Pharmacol Rev, 46, 157
Saper CB. Brain stem modulation of sensation, movement, and consciousness. In: Kandel ER, Schwartz JH, Jessell TM, eds. Principles of neural science. 4th ed. New York: McGraw-Hill, 2000:896.
Kline SS, 1989, Clin Pharm, 8, 510
Whyte I, 2002, J Toxicol Clin Toxicol, 40, 668
Boddy R, 2004, J Toxicol Clin Toxicol, 42, 725
Olsen D, 2004, J Toxicol Clin Toxicol, 42, 744

Sorted by citations

American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,372
Neurobiology of resilience
Russo, S. J., Murrough, J. W., Han, M.-H., Charney, D. S., & Nestler, E. J. (2012) · Nature Neuroscience · doi:10.1038/nn.3234 · Cited by 1,206
Practice parameter for the assessment and treatment of children and adolescents with depressive disorders
Birmaher, B., & Brent, D. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318145ae1c · Cited by 1,056
Neonatal Drug Withdrawal
Hudak, M. L., Tan, R. C., Frattarelli, D. A. C., Galinkin, J. L., Green, T. P., Neville, K. A., Paul, I. M., van den Anker, J. N., Papile, L. A., Baley, J. E., et al. (2012) · PEDIATRICS · doi:10.1542/peds.2011-3212 · Cited by 889
European Resuscitation Council Guidelines for Resuscitation 2005
Soar, J., Deakin, C. D., Nolan, J. P., Abbas, G., Alfonzo, A. V. M., Handley, A. J., Lockey, D., Perkins, G. D., & Thies, K. (2005) · Resuscitation · doi:10.1016/j.resuscitation.2005.10.004 · Cited by 831
Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications
Franzen, P. L., & Buysse, D. J. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.4/plfranzen · Cited by 747
Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness
Youdim, M. B. H., & Bakhle, Y. S. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706464 · Cited by 652
The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: Electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution
Soar, J., Perkins, G. D., Abbas, G., Alfonzo, A. V. M., Barelli, A., Bierens, J. J. L. M., Brugger, H., Deakin, C. D., Dunning, J., Georgiou, M., et al. (2010) · Resuscitation · doi:10.1016/j.resuscitation.2010.08.015 · Cited by 604
Chronic Pain and Mental Health Disorders
Hooten, W. M. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.04.029 · Cited by 571
Serotonin: a review
MOHAMMAD‐ZADEH, L. F., Moses, L. L., & Gwaltney‐Brant, S. M. (2008) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2008.00944.x · Cited by 535
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults
Kennedy, S. H., Lam, R. W. M., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.043 · Cited by 529
Cellular and molecular actions of Methylene Blue in the nervous system
Öz, M., Lorke, D. E., Hasan, M. Y., & Petroianu, G. A. (2009) · Medicinal Research Reviews · doi:10.1002/med.20177 · Cited by 460
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults.
Lam, R. W., Kennedy, S. H., Grigoriadis, S., McIntyre, R. S., Milev, R., Ramasubbu, R., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.041 · Cited by 431
Serotonin and Blood Pressure Regulation
Watts, S. W., Morrison, S. F., Davis, R. P., & Barman, S. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004697 · Cited by 406
(–)-(1 R,2 R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol Hydrochloride (Tapentadol HCl): a Novel μ-Opioid Receptor Agonist/Norepinephrine Reuptake Inhibitor with Broad-Spectrum Analgesic Properties
Tzschentke, T., Christoph, T., Kögel, B. Y., Schiene, K., Hennies, H. ‐., Englberger, W., Haurand, M., Jahnel, U., Cremers, T. I. F. H., Friderichs, E., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.126052 · Cited by 395
Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: Population based case-control study
Rai, D., Lee, B. K., Dalman, C., Golding, J., Lewis, G., & Magnusson, C. (2013) · BMJ · doi:10.1136/bmj.f2059 · Cited by 365
Delirium in critically ill patients: Impact on long-term health-related quality of life and cognitive functioning*
van den Boogaard, M., Schoonhoven, L., Evers, A. W. M., van der Hoeven, J. G., van Achterberg, T., & Pickkers, P. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31822e9fc9 · Cited by 361
Chemotherapy in Psychiatry
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Trends in Tramadol: Pharmacology, Metabolism, and Misuse
Miotto, K. A., Cho, A. K., Khalil, M. A. E. F., Blanco, K., Sasaki, J. D., & Rawson, R. A. (2016) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001683 · Cited by 355
Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines
Dumbreck, S., Flynn, A., Nairn, M., Wilson, M., Treweek, S. P., Mercer, S. W., Alderson, P., Thompson, A., Payne, K., & Guthrie, B. (2015) · BMJ · doi:10.1136/bmj.h949 · Cited by 347
Khat and synthetic cathinones: a review
Valente, M. J., de Pinho, P. G., Bastos, M. D. L., Carvalho, F. D., & Carvalho, M. C. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1163-9 · Cited by 336
Efficacy of Antidepressants as Analgesics: A Review
Dharmshaktu, P., Tayal, V., & Kalra, B. S. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010394852 · Cited by 326
Novel psychoactive substances of interest for psychiatry
Schifano, F., Orsolini, L., Duccio Papanti, G., & Corkery, J. M. (2015) · World Psychiatry · doi:10.1002/wps.20174 · Cited by 321
Comprehensive review of cardiovascular toxicity of drugs and related agents
Mladěnka, P., Applová, L., Patočka, J., Costa, V. M., Remião, F., Pourová, J., Mladěnka, A., Karlíčková, J., Jahodář, L., Vopršalová, M., et al. (2018) · Medicinal Research Reviews · doi:10.1002/med.21476 · Cited by 335
Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews
Kroenke, K., Krebs, E. E., & Bair, M. J. (2009) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.12.006 · Cited by 308
Obsessive Compulsive Disorder
Hudak, R., & Gannon, J. M. (2022) · Current clinical practice · doi:10.1007/978-3-030-98709-1_5 · Cited by 306
Brain–heart interactions: physiology and clinical implications
Silvani, A., Buonaura, G. C., Dampney, R. A. L., & Cortelli, P. (2016) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2015.0181 · Cited by 324
A patient with encephalitis associated with NMDA receptor antibodies
Sansing, L. H., Tüzün, E., Ko, M. W., Baccon, J., Lynch, D. R., & Dalmau, J. O. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0493 · Cited by 290
Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction
Ramsay, R. R., Dunford, C., & Gillman, P. K. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707430 · Cited by 276
Melatonin Natural Health Products and Supplements: Presence of Serotonin and Significant Variability of Melatonin Content
Erland, L. A. E., & Saxena, P. K. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6462 · Cited by 273
Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions
Scotton, W. J., Hill, L. J., Williams, A. C., & Barnes, N. M. (2019) · International Journal of Tryptophan Research · doi:10.1177/1178646919873925 · Cited by 288
Catatonia: Clinical Aspects and Neurobiological Correlates
Daniels, J. E. (2009) · Journal of Neuropsychiatry · doi:10.1176/jnp.2009.21.4.371 · Cited by 261
Methylene blue and Alzheimer's disease
Öz, M., Lorke, D. E., & Petroianu, G. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.034 · Cited by 269
Declines in mental health associated with air pollution and temperature variability in China
Xue, T., Zhu, T., Zheng, Y., & Zhang, Q. (2019) · Nature Communications · doi:10.1038/s41467-019-10196-y · Cited by 260
A Review of Serotonin Toxicity Data: Implications for the Mechanisms of Antidepressant Drug Action
Gillman, P. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.016 · Cited by 245
Tramadol, Pharmacology, Side Effects, and Serotonin Syndrome: A Review
Kaye, A. D. (2015) · Pain Physician · doi:10.36076/ppj.2015/18/395 · Cited by 247
The therapeutic potentials of Ayahuasca: possible effects against various diseases of civilization
Frecska, E., Bokor, P., & Winkelman, M. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00035 · Cited by 242
Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids.
Gable, R. S. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01652.x · Cited by 244
Combination pharmacotherapy for management of chronic pain: from bench to bedside
Gilron, I., Jensen, T. S., & Dickenson, A. H. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70193-5 · Cited by 250
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232
Pain Assessment and Treatment in Children With Significant Impairment of the Central Nervous System
Hauer, J., Houtrow, A. J., Feudtner, C., Klein, S. M., Klick, J. C., Linebarger, J., Norwood, K. W., Adams, R. C., Brei, T. J., Davidson, L. F., et al. (2017) · PEDIATRICS · doi:10.1542/peds.2017-1002 · Cited by 230
Late-Life Depression
Unützer, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp073754 · Cited by 223
Linezolid: a review of safety and tolerability
Vinh, D. C., & Rubinstein, E. (2009) · Journal of Infection · doi:10.1016/s0163-4453(09)60009-8 · Cited by 218
Catatonia and the immune system: a review
Rogers, J. P., Pollak, T. A., Blackman, G., & David, A. S. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30190-7 · Cited by 221
Antidepressants for the Treatment of Chronic Pain
Verdu, B., Décosterd, I., Buclin, T., Stiefel, F., & Berney, A. (2008) · Drugs · doi:10.2165/0003495-200868180-00007 · Cited by 215
Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's Disease
CHEN, J., Swope, D., & Dashtipour, K. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.09.021 · Cited by 207
Postoperative delirium. Part 1
Steiner, L. A. (2011) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e328349b7f5 · Cited by 208
Serotonin Toxicity Associated with the Use of Linezolid: A Review of Postmarketing Data
Lawrence, K. R., Adra, M., & Gillman, P. K. (2006) · Clinical Infectious Diseases · doi:10.1086/503839 · Cited by 203
The Pathophysiology of Serotonin Toxicity in Animals and Humans
Isbister, G. K., & Buckley, N. A. (2005) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000177642.89888.85 · Cited by 200
Serotonin—Its Synthesis and Roles in the Healthy and the Critically Ill
Káňová, M., & Kohout, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094837 · Cited by 200
The promises and perils of psychedelic pharmacology for psychiatry
McClure‐Begley, T. D., & Roth, B. L. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00421-7 · Cited by 202
Fever of Unknown Origin
Haidar, G., & Singh, N. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2111003 · Cited by 200
Monoamine Oxidase Inhibitors:A Modern Guide to an Unrequited Class of Antidepressants
Stahl, S. M., & Felker, A. (2008) · CNS Spectrums · doi:10.1017/s1092852900016965 · Cited by 191
Linezolid‐Associated Peripheral and Optic Neuropathy, Lactic Acidosis, and Serotonin Syndrome
Narita, M., Tsuji, B. T., & Yu, V. L. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.8.1189 · Cited by 191
Hypolocomotion, anxiety and serotonin syndrome‐like behavior contribute to the complex phenotype of serotonin transporter knockout mice
Kalueff, A. V., Fox, M. A., Gallagher, P. S., & Murphy, D. L. (2006) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2006.00270.x · Cited by 187
Drug-induced tremors
Morgan, J. C., & Sethi, K. D. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70250-7 · Cited by 186
CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity
Gillman, P. K. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109359098 · Cited by 183
Hypericum perforatum : Pharmacokinetic, Mechanism of Action, Tolerability, and Clinical Drug-Drug Interactions
Russo, E., Scicchitano, F., Whalley, B. J., Mazzitello, C., Ciriaco, M., Esposito, S., Patanè, M., Upton, R., Pugliese, M., Chimirri, S., et al. (2013) · Phytotherapy Research · doi:10.1002/ptr.5050 · Cited by 181
Toxicities of opioid analgesics: respiratory depression, histamine release, hemodynamic changes, hypersensitivity, serotonin toxicity
Baldo, B. A. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03068-2 · Cited by 188
Serotonin, But Not N -Methyltryptamines, Activates the Serotonin 2A Receptor Via a β-Arrestin2/Src/Akt Signaling Complex In Vivo
Schmid, C. L., & Bohn, L. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1665-10.2010 · Cited by 181
Drug-induced serotonin syndrome: a review
Sun‐Edelstein, C., Tepper, S. J., & Shapiro, R. E. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740338.7.5.587 · Cited by 167
The clinical toxicology of metamfetamine
Schep, L. J., Slaughter, R. J., & Beasley, D. M. G. (2010) · Clinical Toxicology · doi:10.3109/15563650.2010.516752 · Cited by 169
New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal
Chouinard, G., & Chouinard, V.-A. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000371865 · Cited by 164
Synthetic Cathinones (“Bath Salts”)
Banks, M. L., Worst, T. J., Rusyniak, D. E., & Sprague, J. E. (2014) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2013.11.104 · Cited by 163
Psychedelic 5-Methoxy-N,N-Dimethyltryptamine: Metabolism, Pharmacokinetics, Drug Interactions, and Pharmacological Actions
Shen, H.-W., Jiang, X.-L., C. Winter, J., & Yu, A.-M. (2010) · Current Drug Metabolism · doi:10.2174/138920010794233495 · Cited by 170
Clinically Significant Drug Interactions with Newer Antidepressants
Spina, E., Trifirò, G., & Caraci, F. (2011) · CNS Drugs · doi:10.2165/11594710-000000000-00000 · Cited by 164
The Serotonin Syndrome: From Molecular Mechanisms to Clinical Practice
Francescangeli, J., Karamchandani, K., Powell, M., & Bonavia, A. S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092288 · Cited by 160
Serotonergic modulation of zebrafish behavior: Towards a paradox
Herculano, A. M., & Maximino, C. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.03.008 · Cited by 166
Legal highs: staying on top of the flood of novel psychoactive substances
Baumeister, D., Tojo, L. M., & Tracy, D. K. (2015) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125314559539 · Cited by 162
Lethal Serotonin Syndrome After Methylone and Butylone Ingestion
Warrick, B. J., Wilson, J., Hedge, M. W., Freeman, S. B., Leonard, K., & Aaron, C. K. (2011) · Journal of Medical Toxicology · doi:10.1007/s13181-011-0199-6 · Cited by 152
Tramadol: Understanding the Risk of Serotonin Syndrome and Seizures
Hassamal, S., Miotto, K. A., Dale, W., & Danovitch, I. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.04.025 · Cited by 151
The excitatory:inhibitory ratio model (EIR model): An integrative explanation of acute autonomic overactivity syndromes
Baguley, I. J. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.04.037 · Cited by 147
Serotonin toxicity of serotonergic psychedelics
Malcolm, B., & Thomas, K. (2022) · Psychopharmacology · doi:10.1007/s00213-021-05876-x · Cited by 138
Linezolid and Serotonergic Drug Interactions: A Retrospective Survey
Taylor, J. J., Wilson, J. W., & Estes, L. L. (2006) · Clinical Infectious Diseases · doi:10.1086/504809 · Cited by 136
Triptans, Serotonin Agonists, and Serotonin Syndrome (Serotonin Toxicity): A Review
Gillman, P. K. (2009) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2009.01575.x · Cited by 135
The clinical toxicology of the designer “party pills” benzylpiperazine and trifluoromethylphenylpiperazine
Schep, L. J., Slaughter, R. J., Vale, J. A., Beasley, D. M. G., & Gee, P. (2011) · Clinical Toxicology · doi:10.3109/15563650.2011.572076 · Cited by 134
Clinical and pharmacological aspects of bath salt use: A review of the literature and case reports
Miotto, K. A., Striebel, J. M., Cho, A. K., & Wang, C. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.06.016 · Cited by 132
Functional and Developmental Identification of a Molecular Subtype of Brain Serotonergic Neuron Specialized to Regulate Breathing Dynamics
Brust, R. D., Corcoran, A. E., Richerson, G. B., Nattie, E., & Dymecki, S. M. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.027 · Cited by 131
A register study of the impact of stopping third trimester selective serotonin reuptake inhibitor exposure on neonatal health
Warburton, W. P., Hertzman, C., & Oberlander, T. F. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01490.x · Cited by 128
The FDA Alert on Serotonin Syndrome With Use of Triptans Combined With Selective Serotonin Reuptake Inhibitors or Selective Serotonin‐Norepinephrine Reuptake Inhibitors: American Headache Society Position Paper
Evans, R. W., Tepper, S. J., Shapiro, R. E., Sun‐Edelstein, C., & Tietjen, G. E. (2010) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01691.x · Cited by 128
Toxicities Associated With NBOMe Ingestion—A Novel Class of Potent Hallucinogens: A Review of the Literature
Suzuki, J., Dekker, M. A., Valenti, E. S., Cruz, F. A., Correa, A. M., Poklis, J. L., & Poklis, A. (2014) · Psychosomatics · doi:10.1016/j.psym.2014.11.002 · Cited by 125
Potential Drug Interactions in Cancer Patients Receiving Supportive Care Exclusively
Riechelmann, R. P., Zimmermann, C., Chin, S. N., Wang, L. E., O'Carroll, A., Zarinehbaf, S., & Krzyzanowska, M. K. (2008) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2007.06.009 · Cited by 125
Current Issues in Sickle Cell Pain and Its Management
Ballas, S. K. (2007) · Hematology · doi:10.1182/asheducation-2007.1.97 · Cited by 125
Animal models of the serotonin syndrome: A systematic review
Haberzettl, R., Bert, B., Fink, H., & Fox, M. A. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.08.045 · Cited by 124
Unmet need for services and interventions among adolescents with mental disorders
Wang, P. S., Sherrill, J., & Vitiello, B. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.1.1 · Cited by 123
The anaesthetist, opioid analgesic drugs, and serotonin toxicity: A mechanistic and clinical review
Baldo, B. A., & Rose, M. A. (2020) · British Journal of Anaesthesia · doi:10.1016/j.bja.2019.08.010 · Cited by 133
Case Scenario: Opioid Association with Serotonin Syndrome
Rastogi, R., Swarm, R. A., Patel, T., & Riou, B. (2011) · Anesthesiology · doi:10.1097/aln.0b013e31823940c0 · Cited by 121
Pharmacologic Management of Temporomandibular Disorders
Hersh, E. V., Balasubramaniam, R., & Pinto, A. (2008) · Oral and Maxillofacial Surgery Clinics of North America · doi:10.1016/j.coms.2007.12.005 · Cited by 125
Novel psychoactive substances: types, mechanisms of action, and effects
Tracy, D. K., Wood, D. M., & Baumeister, D. (2017) · BMJ · doi:10.1136/bmj.i6848 · Cited by 131
Methylene Blue for Distributive Shock: A Potential New Use of an Old Antidote
Jang, D. H., Nelson, L. S., & Hoffman, R. S. (2013) · Journal of Medical Toxicology · doi:10.1007/s13181-013-0298-7 · Cited by 122
Delirium in critically ill patients
Slooter, A. J. C., van de Leur, R. R., & Zaal, I. J. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63599-0.00025-9 · Cited by 125
Serotonin syndrome: Preventing, recognizing, and treating it
Wang, R. Z., Vashistha, V., Kaur, S., & Houchens, N. W. (2016) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.83a.15129 · Cited by 115
Antidepressant Withdrawal and Rebound Phenomena
Henssler, J., Heinz, A., Brandt, L., & Bschor, T. (2019) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2019.0355 · Cited by 50
Polypharmacy in Patients With Advanced Cancer and Pain: A European Cross-Sectional Study of 2282 Patients
Kotlińska–Lemieszek, A., Paulsen, Ø., Kaasa, S., & Klepstad, P. (2014) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2014.03.008 · Cited by 113
Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications
Oberlander, T. F., Bonaguro, R. J., Misri, S. K., Papsdorf, M., Ross, C. J., & Simpson, E. M. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002007 · Cited by 113
Heatwaves, medications, and heat-related hospitalization in older Medicare beneficiaries with chronic conditions
Layton, J. B., Li, W., Yuan, J., Gilman, J. P., Horton, D. B., & Setoguchi, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243665 · Cited by 119
Adverse drug events associated with linezolid administration: a real-world pharmacovigilance study from 2004 to 2023 using the FAERS database
Zou, F., Cui, Z., Lou, S., Ou, Y., Zhu, C., Shu, C., Chen, J., Zhao, R., Wu, Z., Wang, L., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1338902 · Cited by 112
Opioid analgesic drugs and serotonin toxicity (syndrome): mechanisms, animal models, and links to clinical effects
Baldo, B. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2244-6 · Cited by 97

Authors: Boyer, E. W., & Shannon, M.
Affiliations: Boston Children's Hospital (US)
ORCID: Boyer, Edward W.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2005-03-17
Volume: 352
Issue: 11
Pages: 1112-1120
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra041867
OpenAlex: W2123778879
Cited by: 1,821
References: 49
Citations by year: 2026: 47 · 2025: 65 · 2024: 84 · 2023: 53 · 2022: 78 · 2021: 74 · 2020: 92 · 2019: 86 · 2018: 99 · 2017: 96 · 2016: 98 · 2015: 112 · 2014: 121 · 2013: 109 · 2012: 93
FWCI: 11.96
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Drug Abuse (DA14929, R21DA014929)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords: serotonin syndrome, adverse drug reactions, drug interactions, self-poisoning, serotonin receptor agonists
MeSH terms: Algorithms, Antidepressive Agents, Diagnostic Errors, Drug Interactions, Humans, Monoamine Oxidase Inhibitors, Selective Serotonin Reuptake Inhibitors, Serotonin Syndrome, Drug Overdose

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Serotonin Syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks